BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30081915)

  • 1. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
    Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
    Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey.
    Lingani M; Akita T; Ouoba S; Nagashima S; Boua PR; Takahashi K; Kam B; Sugiyama A; Nikiema T; Yamamoto C; Somé A; Derra K; Ko K; Sorgho H; Tarnagda Z; Tinto H; Tanaka J
    BMC Infect Dis; 2020 Jan; 20(1):46. PubMed ID: 31941454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso].
    Sangaré L; Sombié R; Combasséré AW; Kouanda A; Kania D; Zerbo O; Lankoandé J
    Bull Soc Pathol Exot; 2009 Oct; 102(4):226-9. PubMed ID: 19950539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region.
    Sanou AM; Ilboudo AK; Meda CZ; Togozia A; Coulibaly A; Cisse A; Sagna T; Kania D; Tarnagda Z
    J Infect Dev Ctries; 2018 Nov; 12(11):1002-1008. PubMed ID: 32012131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
    Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C; Zanchi R; Seck A; Garin B; Giles-Vernick T; Gody JC; Bata P; Pondy A; Tetang SM; Ba M; Ekobo CS; Rousset D; Sire JM; Maylin S; Chartier L; Njouom R; Vray M
    BMC Infect Dis; 2015 Jul; 15():267. PubMed ID: 26164361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of hepatitis B virus infection and impact of vaccination.
    Huang P; Zhu LG; Zhu YF; Yue M; Su J; Zhu FC; Yang HT; Zhang Y; Shen HB; Yu RB; Zhai XJ; Peng ZH
    World J Gastroenterol; 2015 Jul; 21(25):7842-50. PubMed ID: 26167084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.
    Sanou AM; Benkirane K; Tinto B; Cissé A; Sagna T; Ilboudo AK; Dording C; Tarnagda Z; Muller CP; Hübschen JM
    Int J Infect Dis; 2018 May; 70():15-19. PubMed ID: 29432880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where we are in the fight against Hepatitis B Infection; Trends in Hepatitis B virus seroprevalence in Black Sea Region of Turkey.
    Igde FA; Taskin H; Igde M; Yazici Z; Atilla A
    Niger J Clin Pract; 2018 Jan; 21(1):87-92. PubMed ID: 29411730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Childs L; Roesel S; Tohme RA
    Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
    Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.